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Abstract
Background: Deworming HIV-1 infected individuals may delay HIV-1 disease progression. It is important to determine the
prevalence and correlates of HIV-1/helminth co-infection in helminth-endemic areas.
Methods: HIV-1 infected individuals (CD4.250 cells/ul) were screened for helminth infection at ten sites in Kenya.
Prevalence and correlates of helminth infection were determined. A subset of individuals with soil-transmitted helminth
infection was re-evaluated 12 weeks following albendazole therapy.
Results: Of 1,541 HIV-1 seropositive individuals screened, 298 (19.3%) had detectable helminth infections. Among individuals
with helminth infection, hookworm species were the most prevalent (56.3%), followed by Ascaris lumbricoides (17.1%), Trichuris
trichiura (8.7%), Schistosoma mansoni (7.1%), and Stongyloides stercoralis (1.3%). Infection with multiple species occurred in 9.4%
of infections. After CD4 count was controlled for, rural residence (RR 1.40, 95% CI: 1.08–1.81), having no education (RR 1.57, 95%
CI: 1.07–2.30), and higher CD4 count (RR 1.36, 95% CI: 1.07–1.73) remained independently associated with risk of helminth
infection. Twelve weeks following treatment with albendazole, 32% of helminth-infected individuals had detectable helminths
on examination. Residence, education, and CD4 count were not associated with persistent helminth infection.
Conclusions: Among HIV-1 seropositive adults with CD4 counts above 250 cells/mm
3 in Kenya, traditional risk factors for
helminth infection, including rural residence and lack of education, were associated with co-infection, while lower CD4
counts were not.
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Introduction
Worldwide, more than 2 billion people are infected with at least
one helminth species.[1] The majority of these infections occur in
resource-limited settings, where over half of the population may
harbor infection.[2] Given the significant geographic overlap of
HIV-1 and helminth infections, a large proportion of HIV-1
infected individuals are likely to be co-infected with at least one
helminth species.[3,4] A pooled analysis of trials of deworming in
HIV-1 infected individuals suggests significant benefit of deworm-
ing on both CD4 counts and plasma viral load.[5] Deworming has
been estimated to reduce HIV-1 RNA by as much as 0.50 log10
copies/ml.[3,4,6] Modeling studies suggest that this magnitude of
effect could delay HIV-1 disease progression by up to 25% and
delay time to the development of AIDS by as much as 3.5
years.[7,8] Despite HIV-1 prevalence rates exceeding 10–20% in
some countries, widespread helminth prevalence surveys among
HIV-1 infected individuals have not been conducted.[9] Because
deworming may be a useful intervention in HIV-1 treatment
programs, it is important to determine burden of helminth
infection and cofactors for helminth infection in HIV-1 infected
adults. However, there are limited surveillance data on helminth
prevalence in HIV-1 infected adults in diverse geographic settings.
As part of a randomized trial of deworming, we determined
prevalence and correlates of helminth infection among 1,541 HIV-
1 infected adults attending ten geographically distinct HIV Care
and Treatment Clinics in Kenya. We also determined factors
associated with soil-transmitted helminth clearance and persis-
tence/re-infection among 91 individuals who received albendazole
as part of the clinical trial (Figure 1).
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Study Design
Antiretroviral-naı ¨ve HIV-1 seropositive adults not meeting
WHO criteria for HAART initiation were screened by stool
microscopy. Study participants were recruited from existing HIV
Care and Treatment programs at ten sites geographically
dispersed throughout Kenya using a mobile study team. Study
sites were District Hospitals in Homa Bay, Kerugoya, Mbagathi,
Thika, Kisumu, Kisii, Machakos and Kilifi, as well as the Kibera
AMREF/CDC Clinic and the Coptic Hope Clinic (Nairobi)
(Figure 2). The study was approved by the Kenya Medical
Research Institute Ethical Review Board and the University of
Washington Institutional Review Board. All participants provided
written informed consent. The study was registered under Clinical
Trials Registration identifier: NCT00130910.
Potentially eligible study participants were identified at each site
by clinic staff and referred for helminth screening. Patients were
eligible for helminth screening if they were HIV-1 seropositive, at
least 18 years of age, non-pregnant and not eligible for initiation of
antiretroviral therapy based on World Health Organization
Figure 1. CONSORT flowchart of study screening and enrollment.
doi:10.1371/journal.pntd.0000644.g001
Author Summary
Over one-third of people worldwide are currently infected
with parasitic worms. The majority of these infections
occur in sub-Saharan Africa, where over half of the
population may be infected with at least one type of
parasitic worm. HIV infection is also common in many of
these countries, and there is significant geographic
overlap in the presence of HIV and worm infection.
Several studies have suggested that treatment of worm
infections in people with HIV may delay the progression
of HIV disease. Treatment has been shown to both
decrease levels of the HIV virus in the blood of people
with HIV and to increase the number of immune cells
(CD4 cells) targeted by HIV. It is important to determine
which populations of HIV-infected individuals are at
greatest risk of worm infection in order to develop
potential interventions for the treatment and prevention
of worm infection in HIV-infected individuals. We report
findings from a large study examining the prevalence and
associated co-factors for worm infection among indivi-
duals at ten sites in Kenya.
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Stage 3, other than for treated tuberculosis). Some individuals
were enrolled based on a CD4 count obtained in the preceding
three months and were subsequently found to have a CD4 count
less than 250 cells/mm
3 from the sample collected at enrollment.
Exclusion criteria included having ever used antiretroviral drugs,
having taken medicine for helminth infection in the preceding six
months, having evidence of active tuberculosis (TB), and having
clinical signs of severe anemia. Potential participants were
informed of the aims and procedures of the study and assessed
for eligibility. Participants were provided with stool collection
containers, instructions on specimen collection, and were
requested to collect stool within six hours of the screening visit.
All female participants were asked to provide a fresh urine sample
for b-human chorionic gonadotropin testing to exclude pregnant
women. Baseline demographic information and a medical history
were obtained from participants at the time of screening.
Individuals with evidence of co-infection with albendazole-
treatable soil-transmitted helminths (A. lumbricoides, T. trichiura or
hookworm sp.) were enrolled into a randomized, double-blind,
placebo controlled trial, details of which have been previously
published.[3] Individuals with schistosomiasis or infection with
Taenia species were treated with open-label praziquantel (and
albendazole if co-infected with other helminths) and were not
enrolled. Individuals with no evidence of helminth infection were
counseled on basic hygiene and avoidance of helminth exposure,
but were not enrolled in the randomized trial. Individuals who
participated in the clinical trial were randomized to albendazole,
(400 mg a day for three days) or placebo and followed for twelve
weeks. CD4 counts and plasma HIV RNA assays were collected at
baseline and at the twelve-week visit (Figure 1).
Laboratory Analysis
Each participant provided a single stool sample separated into a
plain collection vial (AlphaTec, California, USA) and a vial
containing preservative (ProtofixCLR, AlphaTec). Each stool
sample was processed within 6 hours of collection and read within
30 minutes of processing. Stool samples were evaluated using wet
preparation, Kato-Katz and formol-ether concentration techni-
ques by an experienced laboratory technician. The presence of
Figure 2. Geographic distribution and prevalence of helminth infection by species and screening region in Kenya. The black dots
represent the relative locations of the ten sites where screening occurred. The number of individuals screened (and percent of total) in each region is
listed. The prevalence of helminth infection in each region is listed below in bold. The number of infections for each species and column percents are
shown for each region.
doi:10.1371/journal.pntd.0000644.g002
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infection, based on number of eggs per gram of stool, was
calculated according to WHO standards.[10] Helminth infection
was defined as the presence of ova or grossly visible helminth on
any single examination.
All randomized participants underwent repeat HIV-1 serologic
testing using Determine
TM rapid test qualitative immunoassay
(Abbott, Japan) and had CD4 counts and plasma viral loads
determined at enrollment and follow-up. Randomized participants
had CD4 counts measured at the time of enrollment using
Multiset
TM software on a FACSCalibur machine (Becton Dick-
inson, USA). Plasma HIV RNA was quantified on samples from
randomized participants using the Gen-Probe HIV-1 viral load
assay, which has been shown to quantify the subtypes of HIV-1
prevalent in Kenya.[11] CD4 count data from within the previous
3 months were abstracted from clinic records for participants who
were screened for helminth infection but not enrolled in the
randomized trial. No plasma viral load data were available for
participants who were not enrolled in the randomized trial.
Statistical Analysis
Analyses were performed using Stata version 9.2 (College
Station, Texas, USA). All HIV-1 seropositive adults who were
screened for helminth infection for the randomized clinical trial
were included in these analyses.
Primary analyses identified correlates of helminth infection
among HIV-1 infected adults, which included; age, gender,
geographic area, education, employment, sanitation, water access,
and CD4 count. Household development index, a composite
measure combining education, sanitation, water source and
occupation, was developed based on similar indexes in the
literature.[12–14] The association between these factors and being
infected with helminths at the time of screening was evaluated
using relative risk regression.[15,16] Multicollinearity was assessed
and a multivariate model of the risk of infection with any helminth
was developed using relative risk regression to assess the
independent effects of the various correlates.
Chi-square tests were used to compare differences in the
proportions of persistent or new infections at the 12 week follow-
up visit after treatment with albendazole. Fisher’s exact test was
used if the expected value in any cell was less than 5. Comparisons
of median CD4 counts and median log10 plasma HIV RNA
between species were done using a Kruskal Wallis test. Stratified
relative risk regression was used to determine the association
between the correlates identified above and the risk of infection for
each species. Because of the large number of analyses conducted
for each species, only statistically significant results (p,0.05) are
presented.
Results
Study Population
Between March 2006 and June 2007, stool from 1,541 HIV-1
infected antiretroviral-naı ¨ve adults at ten geographically distinct
sites in Kenya was screened for evidence of helminth infection.
The mean age of the participants was 35.5 years (range 18–80) and
74.5% percent were female. Most had less than a secondary school
education (63%) and about half (51.5%) reported an income-
generating occupation other than farming. Few individuals had
access to piped water (12.3%), although most reported access to
some form of latrine or toilet (93.6%). Individuals were recruited
from urban clinics within Nairobi (44.7%), peri-urban clinics
surrounding Nairobi (27.7%), rural clinics in western Kenya
(13.8%) or a rural coastal clinic (13.8%). Based on eligibility
criteria, individuals in this cohort were relatively immunocompe-
tent (median CD4 count 410 cells/mm
3, IQR 297-586). Median
HIV-1 RNA was 5.0 log10 copies/mL, IQR: 4.3-5.4) in the subset
of participants enrolled in the clinical trial.
A total of 298 (19.3%) individuals had evidence of infection with
at least one species of helminth and 234 were enrolled into the
randomized trial. Hookworm species was the most prevalent
helminth identified, 56.4% (n=168), followed by Ascaris lumbri-
coides, 17.1% (n=51), Trichuris trichiura, 8.7% (n=26), Schistosoma
mansoni, 7.3% (n=21), and Stongyloides stercoralis, 1.3% (n=4).
Mixed infection with at least two different helminth species was
identified in 28 individuals (9.4%). Using WHO criteria, the
majority of the infections were classified as being ‘‘light burden’’
with only 5 ‘‘moderate’’ and 2 ‘‘heavy burden’’ infections
identified[10].
Correlates of Helminth Co-infection
The geographic distribution of helminth infection in Kenya is
displayed in Figure 2. Individuals in rural areas were more likely to
be infected with at least one species of helminth compared to
individuals in urban areas (RR 1.85, 95% CI 1.51–2.26).
Demographic characteristics including age, gender, education
and occupation were evaluated as correlates for risk of helminth
infection by univariate analysis (Table 1). There was a trend
towards a lower risk of helminth infection with increasing age by
decade (RR 0.88, 95% CI: 0.78–1.00). No statistically significant
differences were found in the gender distribution between
helminth infected and uninfected individuals. Lack of education
was associated with an increased risk of helminth infection.
Compared to individuals who completed secondary education,
individuals with a primary school education were 29% more likely
to be infected with any helminth (RR 1.29, 95% CI 0.99–1.68)
and those with no education had nearly twice the risk of infection
(RR 1.90, 95% CI 1.34–2.69). There was an increased risk of
helminth infection among individuals who reported farming as an
occupation compared to those with a non-farming occupation (RR
1.59, 95% CI 1.22–2.06).
Lack of access to clean water and adequate sanitation were also
predictors of helminth co-infection. Compared to individuals with
access to pipedwater in their homes, individuals obtainingwater from
a lake, river or pond had almost 2.5-fold increased risk of helminth
infection (RR 2.43, 95% CI 1.55–3.81). When compared to
individuals with access to a flush toilet, individuals with a pit latrine
were twice as likely to be co-infected with helminths (RR 1.99, 95%
CI 1.40–2.83), and those with no latrine were .3-fold more likely to
have a helminth infection (RR 3.39, 95% CI 2.26–5.08) (Table 1).
Individuals with the poorest householddevelopment index (HDI) had
more than 2.5 times the risk of having a soil-transmitted helminth
infection (RR 2.58, 95% CI 1.17–5.70) when compared to
individuals with the most resources (Table 2). However, HDI was
not associated with risk of infection from S. mansoni.
Baseline CD4 count was correlated with risk of helminth
infection in this cohort. The study aimed to recruit pre-HAART
individuals with CD4 counts greater than 250 cells. Participants
were allowed to give CD4 count measurements from their prior
HIV Care and Treatment Clinic visit if these fell within 3 months
of the screening date. However, when these CD4 counts were
confirmed, many people had lower CD4 counts than recorded by
history. Eighty-nine participants had CD4 counts between 0–
199 cells/mL
3 and 256 participants had CD4 counts between 200–
349 cells/mL
3. Compared to individuals with CD4 counts less than
349 cells/mL, those with higher CD4 counts ($350 cells/mL) were
40% more likely to be infected with any helminth (RR 1.40, 95%
CI: 1.12–1.76) (Table 1). HIV-1 RNA levels were not available for
HIV/Helminth Co-infection in Kenya
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helminth infection), precluding an analysis of HIV-1 RNA as a
correlate of helminth infection.
In a multivariate model including CD4 count, rural residence,
education, water source, sanitation and occupation, higher CD4 count
(RR 1.36, 95% CI: 1.07–1.73), rural residence (RR 1.40, 95% CI:
1.08–1.81), and having no education (RR 1.57, 95% CI: 1.07–2.30)
remained independently associated with risk of helminth infection.
Species-Specific Analyses
Species specific analyses were performed on all individual
species with the exception of S. stercoralis (due to the small sample
size (n=4)). Correlates associated with species-specific infections
are presented in Table 3. Hookworm species accounted for 56% of
all infections in this population, and correlates associated with
hookworm infection were similar to the correlates associated with
any helminth infection in the overall cohort, with the exception
that hookworm infection was not associated with farming
occupation (p.0.05). Farming occupation was associated with
increased risk of infection with A. lumbricoides (RR 2.02, 95% CI:
1.05–3.88), S. mansoni (RR 8.62, 95% CI: 2.78–26.8), and multiple
species (RR 2.82, 95% CI: 1.03–7.67) when compared to
individuals employed in non-farming occupations (Table 3). In
addition, individuals living in Western Kenya were more likely to
be infected with A. lumbricoides (RR 2.10, 95% CI: 1.09–4.07) and
S. mansoni (RR 7.53, 95% CI: 1.90–29.8) when compared to
individuals living in urban Nairobi.
There were no differences in the median CD4 counts of
individuals infected with different helminth species (p=0.27)
(Figure 3). Plasma log10 HIV RNA levels were similar between
helminth species in the subset of individuals with available HIV-1
RNA levels (p=0.10) (Figure 3).
Risk of Persistent or Repeated Infection
At the twelve-week follow-up visit, 179 individuals (76.5%) of
the 234 individuals enrolled in the clinical trial provided stool
Table 1. Correlates of helminth infection among HIV-1 seropositive adults in Kenya.
Characteristic n
Helminth Infected
(n=298)
Helminth Uninfected
(n=1243) RR (95% CI)
Age (years); mean (SD) 1488 34.4 (9.5) 35.7 (9.3) 0.88 (0.78, 1.00)*
Gender; n (%)
Male 382 63 (22.3) 319 (26.3) Reference
Female 1114 220 (77.7) 894 (73.7) 1.20 (0.93, 1.54)
Site; n (%)
Nairobi (urban) 689 101 (33.9) 588 (47.3) Reference
Greater-Nairobi (peri-urban) 427 74 (24.8) 358 (28.4) 1.18 (0.90, 1.56)
Western (rural) 213 62 (20.8) 151 (12.1) 1.99 (1.51, 2.62)
Costal (rural) 212 61 (20.5) 151 (12.2) 1.96 (1.49, 2.59)
Education; n (%)
None 132 38 (14.1) 94 (7.9) 1.90 (1.34, 2.69)
Primary 782 153 (56.7) 629 (53.2) 1.29 (0.99), 1.68)
Secondary 449 68 (25.2) 381 (32.2) Reference
Post-secondary 89 11 (4.1) 78 (6.8) 0.82 (0.45, 1.48)
Water source; n (%)
Piped water in home 182 21 (7.5) 161 (13.4) Reference
Communal water source 800 141 (50.2) 659 (54.8) 1.52 (0.99, 2.35)
Lake, river or pool 239 67 (23.8) 172 (14.3) 2.43 (1.55, 3.81)
Other 263 52 (18.5) 211 (17.5) 1.71 (1.07, 2.74)
Sanitation; n (%)
Access to flush toilet 296 34 (12.1) 262 (21.6) Reference
No toilet or latrine 95 37 (13.2) 58 (4.8) 3.39 (2.26, 5.08)
Pit latrine for single home 491 112 (39.9) 379 (31.3) 1.99 (1.40, 2.83)
Shared pit latrine 610 98 (34.9) 512 (42.3) 1.40 (0.97, 2.01)
Employment; n (%)
Employed, non-farmer 767 125 (44.3) 642 (53.2) Reference
Employed, farmer 263 68 (24.1) 195 (16.1) 1.59 (1.22, 2.06)
Not employed 460 89 (31.6) 371 (30.7) 1.19 (0.93, 1.52)
CD4 count (cells/mL); n (%)
0 – 349 372 81 (30.3) 291 (40.8) Reference
$350 608 186 (69.7) 422 (59.2) 1.40 (1.12, 1.76)
*Comparisons by years in decades.
doi:10.1371/journal.pntd.0000644.t001
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in the treatment arm were significantly more likely to have
evidence of cleared helminth infection at follow up than those in
the placebo arm (68.1% vs. 51.1%, p=0.02). Of those with
evidence of helminth infection at follow-up (n=72), 61.1% (44/
72) had hookworm infection, 16.7% (12/72) had A. lumbricoides,
11.1% (8/72) had mixed infection, 6.9% (5/72) had T. trichiura
a n d4 . 2 %( 3 / 7 2 )h a dS .m a n s o n iinfection. Baseline median
CD4 counts were similar between those with infection at follow-
up and those without (489 vs. 474, p=0.99), as were baseline
median log10 HIV RNA levels (5.1 log10 vs 4.9 log10 HIV RNA,
p=0.29). The distribution of initial and follow-up species-
specific infections by treatment arm is displayed in Figure 4.
There were no differences noted in the age, gender, educational
level, occupation, access to sanitation or clean water between
those who cleared their helminth infection and those who were
infected at follow-up.
Discussion
This study describes the prevalence and correlates of helminth
co-infection among antiretroviral naı ¨ve, HIV-1 infected adults in
Kenya. Helminth infection was common in HIV-1 infected adults
in this study, with distinct geographic and sociodemographic risk
factors for infection with different helminth species. Rural
residence and education were independently associated with risk
of helminth infection in this cohort and are similar to risk factors
described in HIV uninfected individuals from similar settings. In
addition, higher CD4 counts were also independently associated
with risk of helminth infetion. In a smaller cohort of albendazole-
treated individuals, helminths were detected relatively frequently
12 weeks after treatment, although region, CD4 count, and
educational level were not associated with persistence/re-infection.
It has been estimated that more than a third of all individuals in
sub-Saharan Africa are infected with at least one species of
helminth, with considerable overlap in the prevalence of helminths
and HIV-1.[17,18] The prevalence and species distribution of
helminth infection in our study were within the range of previously
published reports of helminth infection in Africa, although lower
than some previous estimates for Sub-Saharan Africa, where
individual species prevalence has been estimated as 25% for
Ascariasis, 29% for hookworm, and 24% for trichuria-
sis.[1,17,19,20] The lower rates of infection in this cohort may
reflect lower prevalence in older age groups and/or the use of a
single stool specimen for diagnosis, which is less sensitive than the
use of three samples used in many surveys.[21] A 24.9%
prevalence of helminth infection was reported in 297 HIV-1
infected individuals in an urban setting in Zambia, which was
higher than noted in population-based helminth surveys from the
same urban population. However, in studies directly comparing
helminth prevalence between HIV-1 infected and uninfected
individuals in Africa, no consistent correlation between HIV-1
infection and increased risk of infection with any helminth species
has been reported.[22–25] Previous studies have been limited by
relatively small sample sizes (60-582 individuals) and have assessed
helminth prevalence at a single site. Our study had a large sample
Table 3. Relative risk of species-specific helminth infection associated with study correlates among HIV-1 seropositive adults in
Kenya, compared to helminth-uninfected individuals.
Correlate
Hookworm sp.
(n=168) RR
(95% CI)
A. lumbricoides
(n=51) RR
(95% CI)
T. trichiura
(n=26) RR
(95% CI)
S. mansoni
(n=21) RR
(95% CI)
Mixed
(n=28) RR
(95% CI)
Rural vs. urban residence 2.40 (1.81–3.17) * * * 2.63 (1.27–5.47)
Increasing age in decades 0.78 (0.66–0.94) * * 1.58 (1.08–2.30) 0.59 (0.36–0.97)
Gender * * * * *
Greater-Nairobi vs. Nairobi * * * 6.48 (1.84–22.8) *
Western vs. Nairobi 2.36 (1.58–3.51) 2.10 (1.09–4.07) * 7.53 (1.90–29.8) *
Coastal vs. Nairobi 2.83 (1.95–4.09) * * * 2.74 (1.12–6.70)
None vs. secondary education 2.22 (1.38–3.58) * 2.92 (1.04–8.22) * 7.82 (1.45–42.0)
Environmental vs. piped water 3.40 (1.61–7.16) * * * *
Communal vs. piped water 2.46 (1.22–4.98) * * * *
No toilet vs. flush 5.08 (2.90–8.90) * * * 8.28 (2.13–32.2)
Pit latrine vs. flush 2.17 (1.30–3.66) * * * *
Farmer vs. non-farmer * 2.02 (1.05–3.88) * 8.62 (2.78–26.8) 2.82 (1.03–7.67)
CD4 0-349 vs. $350 cells/mL 1.50 (1.10–2.05) * * * *
*Non-statistically significant relative risk.
doi:10.1371/journal.pntd.0000644.t003
Table 2. Risk of helminth infection by household
development index (HDI).
HDI levela
Soil-transmitted helminth
(N=264) S. mansoni (N=21)
% RR (95% CI) % RR (95% CI)
Level 1 2.3 Reference 4.8 Reference
Level 2 68.6 2.20 (1.01, 4.79) 76.2 1.31 (0.18, 9.74)
Level 3 29.2 2.58 (1.17, 5.70) 19.1 0.95 (0.11, 8.34)
aHousehold development levels are defined as: Level 1 (most developed)
participant has access to a flush toilet in home, water piped into their house,
an income generating occupation, and has completed, at least, secondary
school; Level 2 participant lacks one, two or three of access to a flush toilet,
water piped into their home, an income generating occupation, and a
secondary education; Level 3 (least developed) participant lacks four of the
above.
doi:10.1371/journal.pntd.0000644.t002
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and rural sites, providing fairly comprehensive assessment of
helminth infection in HIV-1 infected adults in urban and rural
throughout Kenya. Our study suggests that helminth prevalence in
HIV-1 infected individuals is similar to general population
prevalence in endemic settings.
In this cohort of HIV-1 infected adults in Kenya, rural
residence, lack of education, poor sanitation, use of environmental
sources of water and farming occupation were associated with
helminth infection. However, in multivariate analyses, only
education and rural residence remained predictive of risk of
infection, suggesting that many of these cofactors share determi-
nants. Poverty, lack of access to safe water and sanitation,
agricultural exposure, household crowding, toileting practices, and
education level are well described risk factors for infection with soil
transmitted helminths.[26–29] Our observations differ from those
reported in a previous study examining co-factors for helminth
infection among HIV-1 infected adults in Lusaka, Zambia, which
failed to find significant associations between water source,
sanitation or occupation and helminth infection status.[30] The
Zambian study was conducted in an urban setting, where
sanitation, access to potable water and occupational exposure
were likely different than the population reported in our study. In
addition, the relatively small sample size included in the Zambian
study (297 individuals) may have limited the power to detect
associations. Our study suggests that correlates of helminth
infection are similar among individuals with and without HIV-1
co-infection.
Helminth infected individuals in this cohort had significantly
higher CD4 counts when compared to helminth uninfected
individuals. It is possible that individuals with lower CD4 counts
may be at lower risk of exposure, for instance by being less active
and less likely to engage in agricultural work. There are conflicting
data on the relationship between HIV-1 related immunosuppres-
sion and the acquisition of helminth infection.[31] Among HIV-1
infected pregnant women in Uganda, CD4 count was inversely
associated with risk of hookworm infection (OR for hookworm
infection per 100 cells/uL increase in CD4 count of 1.16 (95% CI
1.02–1.31)).[32] However, declining CD4 counts have been
associated with higher burdens and greater severity of Strongyloides
infection.[33] In addition, significant reductions in the prevalence
of A. lumbricoides, T. Trichiura, hookworm sp., and Strongyloides have
been reported following the introduction of highly active
antiretroviral therapy (HAART), suggesting that HAART may
result in improved immunologic protection and control of
helminth infection.[33–40] In this study, only individuals with
helminth infection were eligible to be enrolled in the randomized
trial, and therefore would have had more recent CD4 data than
helminth uninfected participants who were not eligible for the
clinical trial. The resulting measurement bias would be expected to
result in lower CD4 counts in those with helminth infection, not
higher counts as observed. It is also important to note that the
study included antiretroviral naı ¨ve individuals with CD4 counts
greater than 250 cells/mm
3 and without WHO Stage 3 or 4
disease, and therefore may not be representative of individuals
with severe HIV-1 related immunosuppression or those on
antiretroviral therapy. Despite these limitations, our study suggests
that moderate immune suppression does not increase susceptibility
to helminth acquisition.
The variable geographic distribution between different species
of soil-transmitted helminths has important implications for
treatment and control programs, particularly because the impact
Figure 3. Median CD4 count and plasma HIV RNA level by helminth species.
aNo HIV RNA data were available for S. stercoralis or S. mansoni.
The study aimed to recruit pre-HAART individuals with CD4 counts greater than 250 cells. Participants were allowed to give CD4 count measurements
from their prior HIV Care and Treatment Clinic visit if it fell within three months of the screening date. However, when these CD4 counts were
confirmed, many people had lower CD4 counts than recorded by history. Eighty-nine participants had CD4 counts between 0–199 cells/mL
3 and 256
participants had CD4 counts between 200–349 cells/mL
3.
doi:10.1371/journal.pntd.0000644.g003
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previously reported that albendazole treatment in A. lumbricoides
co-infected individuals resulted in significant CD4 benefit but this
effect was not seen for other helminths.[5] Previous studies also
suggest that treatment of A. lumbricoides, S. mansoni, and lymphatic
filiariasis may result in delaying HIV-1 disease progression, while
treatment of T. trichiura and hookworm species may not.[3,6,42]
These differences may be attributable to significant differences in
the level of tissue invasiveness, antigen burden, duration of
infection and host immune response between species.[42,43] We
found that approximately one-sixth (17.1%) of all helminth
infections among HIV-1 infected adults in Kenya and 11.1% of
detectable infections following albendazole treatment were due to
A. lumbricoides. The prevalence of ascariasis likely reflects the age of
the included population and is consistent with prior studies in the
general population, which showed that A. lumbricoides prevalence
peaks before age 10 and then decreases with age.[20,44] The most
prevalent species we detected was hookworm (56.4% of infections).
This is higher than in population-based prevalence surveys in
Kenya where hookworm accounts for 36-46% of infections, but
consistent with reported higher prevalence rates of hookworm with
increasing age[20,45,46] Despite suboptimal detection techniques
for schistosomal infections in this cohort, S. mansoni was prevalent
among individuals screened in western and central Kenya, where
it has previously been reported to be endemic.[47]
Almost a third (32.1%) of the individuals receiving three doses of
albendazole in this trial returned with helminth infection after 12
weeks. It is not clear whether the infections detected at follow-up
represent treatment failures or repeat infections. While albenda-
zole is not completely effective for the treatment of helminth
infections, individuals also returned to the same home environ-
ments following treatment, suggesting continuous environmental
exposure to infection risk. Our findings suggest that repeated
treatment, in combination with health education programs to
minimize exposure risk, may be needed to maximize the efficacy of
deworming in HIV-1 infected individuals.
Strengths of this study include the screening of a large number
of HIV-1 infected individuals from geographically distinct sites in
Kenya for helminth infection, the use of a combination of
screening techniques to increase the sensitivity of helminth
diagnosis, and the systematic measurement of outcome measures
with a randomized trial. However, this study also had limitations.
While the combination screening methods used in this study are
widely accepted, they have poor sensitivity for the detection of soil-
transmitted helminth species.[48] The variability in sensitivity of
stool diagnostic techniques is evident in the failure to detect
helminth infection in half of individuals with previously detected
helminths who received placebo. In addition, individuals were not
screened with sensitive detection methods for schistosomiasis or
strongyloidiasis. It is likely that we underestimated the true
prevalence of helminth infection. This misclassification would
have decreased the detection and the strength of reported
associations. Approximately forty-five percent of study participants
were recruited in Nairobi, which may have over-sampled
individuals residing in urban populations. However, living
conditions in areas of Nairobi (such as Kibera, Kerugoya or other
Figure 4. Species-specific helminth infection twelve weeks after albendazole or placebo treatment.
1Total number of individuals with
follow-up stool available, stratified by species of initial infection and treatment arm. ALB, albendazole; PLC, placebo.
doi:10.1371/journal.pntd.0000644.g004
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water sources, all potential environmental sources of helminth
infection. Finally, we excluded individuals with CD4,250 cells/
mm
3, which limited ability to determine effects of severe
immunosuppression.
In summary, co-infection with HIV-1 and helminths is common
among adults in Kenya and is associated with rural residence and
lack of education. Moderate immunosuppression does not appear
to increase the risk of helminth acquisition in HIV-1 infected
adults. A combination of repeated deworming with anti-
helminthics, as well as education on helminth-prevention, may
be necessary to eradicate helminths in HIV-1 infected adults.
Given the relatively high prevalence of helminth infection
documented in this study and the available data suggesting
possible benefit of deworming on markers of HIV-1 disease
progression, measures to eradicate and prevent helminth infections
may be a feasible public intervention that complements other
interventions to delay immunosuppression in HIV-1 infected
individuals.
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